Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with bipolar disorders or ...

CNW/ - Holder of an innovative diagnostic support technology, recognized by the Food and Drug Administration (FDA) as a major ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Gary Fisher became a constant companion for the Princess Leia actress later in her life. Carrie Fisher was diagnosed with ...

A Louisiana grand jury has issued an arrest warrant against a New York doctor for allegedly prescribing abortion pills to a ...

BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...

The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 point ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

The story of Hamilton County is the story of much of America in 2025. Overdose deaths have fallen sharply, offering hope the ...

New research pinpoints 298 parts of the genome associated with higher risk of bipolar disorder. This could lead to better ...

The review comes after a series of in-custody deaths, an investigation into an alleged smuggling ring, and a staffing crisis across the system.

Jack Moll has struggled with addiction for much of his adult life, starting with Oxycontin and switching to heroin. “It is ...